{
    "id": 32033,
    "fullName": "PALB2 Y1183*",
    "impact": "nonsense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "PALB2 Y1183* results in a premature truncation of the Palb2 protein at amino acid 1183 of 1186 (UniProt.org). Y1183* confers a loss of function to the Palb2 protein as demonstrated by decreased protein stability (PMID: 31757951), and impaired homology-directed DNA repair activity compared to wild-type in cultured cells lacking Tp53 (PMID: 31636395, PMID: 31757951).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 17535,
                    "pubMedId": 31757951,
                    "title": "Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31757951"
                },
                {
                    "id": 17540,
                    "pubMedId": 31636395,
                    "title": "Functional characterization of 84 PALB2 variants of uncertain significance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31636395"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 79728,
        "geneSymbol": "PALB2",
        "terms": [
            "PALB2",
            "FANCN",
            "PNCA3"
        ]
    },
    "variant": "Y1183*",
    "createDate": "01/13/2020",
    "updateDate": "01/13/2020",
    "referenceTranscriptCoordinates": {
        "id": 186457,
        "transcript": "NM_024675",
        "gDna": "chr16:g.23603471G>T",
        "cDna": "c.3549C>A",
        "protein": "p.Y1183*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20243,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with Lynparza (olaparib) resulted in decreased survival of TP53-knockout cells expressing PALB2 Y1183* in culture (PMID: 31757951).",
            "molecularProfile": {
                "id": 34494,
                "profileName": "PALB2 Y1183*"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17535,
                    "pubMedId": 31757951,
                    "title": "Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31757951"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34494,
            "profileName": "PALB2 Y1183*",
            "profileTreatmentApproaches": [
                {
                    "id": 19934,
                    "name": "PARP Inhibitor (Pan)",
                    "profileName": "PALB2 Y1183*"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 186457,
            "transcript": "NM_024675",
            "gDna": "chr16:g.23603471G>T",
            "cDna": "c.3549C>A",
            "protein": "p.Y1183*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}